genetically modified cells

Read more about the article First revision of EMA guideline on quality, non-clinical and clinical aspects of medicinal products containing genetically modified cells

First revision of EMA guideline on quality, non-clinical and clinical aspects of medicinal products containing genetically modified cells

In November 2020, the Committee for Medicinal Products for Human Use (CHMP) adopted a revision on the EMA’s Guideline on quality, non-clinical and clinical aspects of medicinal products containing genetically…

Continue ReadingFirst revision of EMA guideline on quality, non-clinical and clinical aspects of medicinal products containing genetically modified cells